166 related articles for article (PubMed ID: 37816733)
1. Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect.
Chu YD; Cheng LC; Lim SN; Lai MW; Yeh CT; Lin WR
Cell Death Dis; 2023 Oct; 14(10):660. PubMed ID: 37816733
[TBL] [Abstract][Full Text] [Related]
2. Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma.
Li Q; Li Y; Xu J; Wang S; Xu Y; Li X; Cai S
Cell Physiol Biochem; 2017; 42(1):397-406. PubMed ID: 28558381
[TBL] [Abstract][Full Text] [Related]
3. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic screen of sixty-eight colorectal cancer cell lines identifies CEACAM6 and CEACAM5 as markers of acid resistance.
Michl J; White B; Monterisi S; Bodmer WF; Swietach P
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2319055121. PubMed ID: 38502695
[TBL] [Abstract][Full Text] [Related]
5. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract][Full Text] [Related]
7. Aldolase triggers metabolic reprogramming in colorectal cancer in hypoxia and stiff desmoplastic microenvironments.
Huang HC; Lin WR; Lim SN; Yeh CT; Yen TH; Alison MR; Chen CS
Colloids Surf B Biointerfaces; 2020 Jun; 190():110969. PubMed ID: 32199265
[TBL] [Abstract][Full Text] [Related]
8. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation.
Ilantzis C; DeMarte L; Screaton RA; Stanners CP
Neoplasia; 2002; 4(2):151-63. PubMed ID: 11896570
[TBL] [Abstract][Full Text] [Related]
9. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells.
Holmer R; Wätzig GH; Tiwari S; Rose-John S; Kalthoff H
BMC Cancer; 2015 Dec; 15():975. PubMed ID: 26673628
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.
Schölzel S; Zimmermann W; Schwarzkopf G; Grunert F; Rogaczewski B; Thompson J
Am J Pathol; 2000 Feb; 156(2):595-605. PubMed ID: 10666389
[TBL] [Abstract][Full Text] [Related]
12. Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.
Lian J; Xia L; Chen Y; Zheng J; Ma K; Luo L; Ye F
Pathol Res Pract; 2019 Nov; 215(11):152597. PubMed ID: 31564566
[TBL] [Abstract][Full Text] [Related]
13. Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients.
Zang M; Hu L; Cao S; Fan Z; Pang L; Li J; Su L; Li C; Liu W; Gu Q; Zhu Z; Yan M; Liu B
Sci Rep; 2017 Sep; 7(1):10773. PubMed ID: 28883649
[TBL] [Abstract][Full Text] [Related]
14. CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling.
Han SU; Kwak TH; Her KH; Cho YH; Choi C; Lee HJ; Hong S; Park YS; Kim YS; Kim TA; Kim SJ
Oncogene; 2008 Jan; 27(5):675-83. PubMed ID: 17653079
[TBL] [Abstract][Full Text] [Related]
15. Cell motility and spreading promoted by CEACAM6 through cyclin D1/CDK4 in human pancreatic carcinoma.
Yan L; Wang Y; Wang ZZ; Rong YT; Chen LL; Li Q; Liu T; Chen YH; Li YD; Huang ZH; Peng J
Oncol Rep; 2016 Jan; 35(1):418-26. PubMed ID: 26497080
[TBL] [Abstract][Full Text] [Related]
16. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
[TBL] [Abstract][Full Text] [Related]
17. ALDOB acts as a novel HBsAg-binding protein and its coexistence inhibits cisplatin-induced HepG2 cell apoptosis.
Wu J; Dan C; Zhao HB; Xiao CX; Liu YP; Si LJ; Ren JL; Guleng B
Crit Rev Eukaryot Gene Expr; 2014; 24(3):181-91. PubMed ID: 25072145
[TBL] [Abstract][Full Text] [Related]
18. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
19. Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression.
Rizeq B; Zakaria Z; Ouhtit A
Cancer Sci; 2018 Jan; 109(1):33-42. PubMed ID: 29110374
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
